The cases of Covid-19 in Maharashtra have seen a whopping rise of 241 percent from 5,127 on June 3 to 17,480 cases on June 13, in 10 days, state well-being bulletin information on Monday.
The state additionally reported 1,885 contemporary Covid circumstances right this moment, which is marginally greater than 1,803 circumstances recorded yesterday.
Maharashtra additionally reported one Covid loss of life whereas the case fatality charge is at 1.86 %.
The daily positivity rate recorded yesterday was 2.71 percent while the national recovery rate was 98.68 percent. Over 195 crore vaccine doses have so far been administered in the country.
Amid a surge in COVID-19 cases in Mumbai and other parts of Maharashtra, medical experts say most of the patients are showing mild symptoms and fatality is low in the present “mild wave”, and also no new virus variant of concern has been observed, reports news agency PTI.
Also Read: Retail price inflation fell to 7.04% in May
The patients were being administered paracetamol, and not Remdesivir drug, which was used for patients in the first and second COVID-19 waves, they said.
Meanwhile, Mumbai has recorded the first cases of three patients with the BA.4 variant, and one patient with the BA.5 variant, according to the latest report from Kasturba Hospital Laboratory. All these patients are from 14 May to 24 May, out of which two are 11-year-old girls and two are males in the 40 to 60 years age group. All these patients have been cured in home isolation. On Monday, a total of 1,885 Covid-19 cases were reported in Maharashtra of which 1,118 were from Mumbai.
India reported 8,084 new Covid-19 cases and 10 deaths, according to data released by the Union Health Ministry Monday. As of Monday, active cases of Covid-19 stood at 47,995. The death tally rose to 5,24,771 and the number of people discharged from hospitals stands at 4,26,57,335, the health ministry’s data also showed.
For all the news update subscribe our YouTube channel ‘DNP India’. You can also follow us on FACEBOOK, INSTAGRAM and TWITTER.